Abstract:BACKGROUND: Emerging evidence suggests that traumatic brain injury (TBI) is a major risk factor for developing neurodegenerative disease later in life. Quantitative susceptibility mapping (QSM) has been used by an increasing number of studies in investigations of pathophysiological changes in TBI. However, generating artefact-free quantitative susceptibility maps in brains with large focal lesions, as in the case of moderate-to-severe TBI (ms-TBI), is particularly challenging. To address this issue, we utilized a novel two-pass masking technique and reconstruction procedure (two-pass QSM) to generate quantitative susceptibility maps (QSMxT; Stewart et al., 2022, Magn Reson Med.) in combination with the recently developed virtual brain grafting (VBG) procedure for brain repair (Radwan et al., 2021, NeuroImage) to improve automated delineation of brain areas. We used QSMxT and VBG to generate personalised QSM profiles of individual patients with reference to a sample of healthy controls.METHODS: Chronic ms-TBI patients (N = 8) and healthy controls (N = 12) underwent (multi-echo) GRE, and anatomical MRI (MPRAGE) on a 3T Siemens PRISMA scanner. We reconstructed the magnetic susceptibility maps using two-pass QSM from QSMxT. We then extracted values of magnetic susceptibility in grey matter (GM) regions (following brain repair via VBG) across the whole brain and determined if they deviate from a reference healthy control group [Z-score < -3.43 or > 3.43, relative to the control mean], with the aim of obtaining personalised QSM profiles.RESULTS: Using two-pass QSM, we achieved susceptibility maps with a substantial increase in quality and reduction in artefacts irrespective of the presence of large focal lesions, compared to single-pass QSM. In addition, VBG minimised the loss of GM regions and exclusion of patients due to failures in the region delineation step. Our findings revealed deviations in magnetic susceptibility measures from the HC group that differed across individual TBI patients. These changes included both increases and decreases in magnetic susceptibility values in multiple GM regions across the brain.CONCLUSIONS: We illustrate how to obtain magnetic susceptibility values at the individual level and to build personalised QSM profiles in ms-TBI patients. Our approach opens the door for QSM investigations in more severely injured patients. Such profiles are also critical to overcome the inherent heterogeneity of clinical populations, such as ms-TBI, and to characterize the underlying mechanisms of neurodegeneration at the individual level more precisely. Moreover, this new personalised QSM profiling could in the future assist clinicians in assessing recovery and formulating a neuroscience-guided integrative rehabilitation program tailored to individual TBI patients.

Quantifying cerebral microbleeds using quantitative susceptibility mapping from magnetization‐prepared rapid gradient‐echo

Cerebral Microbleeds: Burden Assessment by Using Quantitative Susceptibility Mapping

Abstract WP292: Quantitative Susceptibility Mapping for Reliably Measuring Hematoma Volume in Magnetic Resonance Imaging

Clinical Quantitative Susceptibility Mapping (QSM): Biometal Imaging and Its Emerging Roles in Patient Care

Hematoma Volume Measurement in Gradient Echo MRI Using Quantitative Susceptibility Mapping.

Determination of Detection Sensitivity for Cerebral Microbleeds Using Susceptibility-Weighted Imaging.

Differentiating calcifications from cerebral microbleeds using quantitative susceptibility mapping

Clinical Feasibility of Brain Quantitative Susceptibility Mapping.

Quantitative susceptibility mapping (QSM) as a means to monitor cerebral hematoma treatment.

Clinical Detection of Cerebral Microbleeds with Quantitative Susceptibility Mapping in Essential Hypertension

MoG-QSM: Model-based Generative Adversarial Deep Learning Network for Quantitative Susceptibility Mapping.

Feasibility of submillimeter functional quantitative susceptibility mapping using 3D echo planar imaging at 7 T

Three‐dimensional EPI with shot‐selective CAIPIRIHANA for rapid high‐resolution quantitative susceptibility mapping at 3 T

Magnetic Susceptibility Source Separation Solely from Gradient Echo Data: Histological Validation

Recommended Implementation of Quantitative Susceptibility Mapping for Clinical Research in The Brain: A Consensus of the ISMRM Electro-Magnetic Tissue Properties Study Group

Characterization of Quantitative Susceptibility Mapping in the Left Ventricle of the Myocardium

Improving quantitative susceptibility mapping for the identification of traumatic brain injury neurodegeneration at the individual level

Multi-echo quantitative susceptibility mapping: how to combine echoes for accuracy and precision at 3 Tesla

Comparison study of quantitative susceptibility mapping with GRAPPA and wave-CAIPI: reproducibility, consistency, and microbleeds detection

Reliability of quantitative magnetic susceptibility imaging metrics for cerebral cortex and major subcortical structures

Automated detection of cerebral microbleeds on T2*-weighted MRI